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ABSTRACT 21 
The Gram-negative bacterial type VI Secretion System (T6SS) delivers toxins to kill or 22 
inhibit the growth of susceptible bacteria, while others target eukaryotic cells. Deletion of 23 
atsR, a negative regulator of virulence factors in B. cenocepacia K56-2, increases T6SS 24 
activity. Macrophages infected with a K56-2 ΔatsR mutant display dramatic alterations in 25 
their actin cytoskeleton architecture that rely on the T6SS, which is responsible for the 26 
inactivation of multiple Rho-family GTPases by an unknown mechanism. We employed 27 
a strategy to standardize the bacterial infection of macrophages and densitometrically 28 
quantify the T6SS-associated cellular phenotype, which allowed us to characterize the 29 
phenotype of systematic deletions of each gene within the T6SS cluster and ten vgrG 30 
encoding genes in K56-2 ΔatsR. None of the genes from the T6SS core cluster and the 31 
individual vgrGs were directly responsible for the cytoskeletal changes in infected cells. 32 
However, a mutant strain with all vgrG genes deleted was unable to cause macrophage 33 
alterations. Despite not being able to identify a specific effector protein responsible for 34 
the cytoskeletal defects in macrophages, our strategy resulted in the identification of the 35 
critical core components and accessory proteins of the T6SS assembly machinery and 36 
provides a screening method to detect T6SS effectors targeting the actin cytoskeleton in 37 
macrophages by random mutagenesis.  38 
39 
 3 
INTRODUCTION 40 
Burkholderia cenocepacia is an environmental Gram-negative opportunistic pathogen 41 
that causes persistent, often severe, lung infections in individuals with cystic fibrosis (CF) 42 
and other underlying diseases (Drevinek & Mahenthiralingam, 2010; Isles et al., 1984; 43 
Mahenthiralingam et al., 2008). Infections by this bacterium are difficult to treat due to 44 
the intrinsic and high-level multidrug resistance of B. cenocepacia to most clinically 45 
relevant antibiotics (Waters, 2012). Also, B. cenocepacia can be transmitted from patient 46 
to patient (Drevinek & Mahenthiralingam, 2010). B. cenocepacia is pathogenic in several 47 
plant and non-mammalian animal infection models (Khodai-Kalaki et al., 2015; Thomson 48 
& Dennis, 2013; Uehlinger et al., 2009; Vergunst et al., 2010) and can survive 49 
intracellularly within epithelial cells (Burns et al., 1996; Sajjan et al., 2006), 50 
macrophages (Lamothe et al., 2007; Martin & Mohr, 2000; Saini et al., 1999) and 51 
amoebae (Lamothe et al., 2004; Marolda et al., 1999). 52 
  53 
The Type VI secretion system (T6SS) is widely distributed among Gram-negative 54 
bacteria (Costa et al., 2015; Zoued et al., 2014). It forms an elongated protein complex, 55 
which is structurally related to the tail-tube and puncturing device of bacteriophages 56 
(Shneider et al., 2013; Zoued et al., 2014). The T6SS is an extremely dynamic contractile 57 
nanomachine (Basler et al., 2012; Bonemann et al., 2010; Clemens et al., 2015; 58 
Kudryashev et al., 2015) that attacks cells by initially penetrating them with a trimeric 59 
protein complex called the VgrG spike. The spike first assembles into a membrane-60 
anchored complex formed of an inner tail tube made of Hcp proteins surrounded by an 61 
outer sheath VipA- and VipB-like proteins (Bonemann et al., 2009). In turn, proteins 62 
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from the PAAR (proline-alanine-alanine-arginine) repeat superfamily bind to the VgrGs 63 
and are essential for T6SS-mediated secretion into other bacterial cells, forming a spike 64 
complex decorated with multiple effectors that are delivered simultaneously into target 65 
cells through a contraction-driven translocation event (Shneider et al., 2013). The AAA+ 66 
ATPase ClpV disassembles the outer sheath complex, a process that requires ATP 67 
hydrolysis, and then the inner Hcp tube is detached and released into the medium 68 
(Bonemann et al., 2009). The T6SS, now referred to as a bacterial poison dagger, is a 69 
versatile weapon, which requires intimate cell contact to deliver a wide range of toxins 70 
into bacterial competitors or eukaryotic cells. Most identified T6SS effector proteins act 71 
on bacterial cells and include peptidoglycan-degrading enzymes, membrane-degrading 72 
lipases, and nucleic acid targeting enzymes (Durand et al., 2014; Russell et al., 2014). In 73 
some cases, the same effector can function in bacterial antagonism and also alters cell-74 
signaling pathways in eukaryotic cells (Jiang et al., 2014). Also, “evolved” VgrGs have 75 
been described that contain various C-terminal extensions leading for instance to actin-76 
crosslinking or actin-ADP-ribosylation in eukaryotic cells (Brooks et al., 2013; Pukatzki 77 
et al., 2007; Suarez et al., 2010), and host cell fusion presumably to facilitate intercellular 78 
bacterial spreading (Schwarz et al., 2014; Toesca et al., 2014).  79 
 80 
The T6SS of B. cenocepacia K56-2 was first identified in a signature-tagged mutagenesis 81 
study pointing out the importance of this secretion system for B. cenocepacia survival in 82 
a rat model of chronic respiratory infection (Aubert et al., 2008; Hunt et al., 2004). Study 83 
of B. cenocepacia T6SS in vitro was rendered possible by the discovery of AtsR 84 
(Adhesion and Type Six secretion system Regulator), a hybrid sensor kinase that 85 
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negatively regulates the expression of B. cenocepacia virulence factors including the 86 
T6SS (Aubert et al., 2010; Aubert et al., 2008; Aubert et al., 2013; Khodai-Kalaki et al., 87 
2013). Deletion of atsR causes a significant increase in T6SS activity, as denoted by 88 
increased amounts of Hcp released into bacterial culture supernatant (Aubert et al., 89 
2008), induction of actin cytoskeletal rearrangements in infected macrophages (Aubert et 90 
al., 2008; Flannagan et al., 2012; Rosales-Reyes et al., 2012), and delayed assembly of 91 
the NADPH oxidase complex at the membrane of the B. cenocepacia-containing vacuole 92 
(Keith et al., 2009; Rosales-Reyes et al., 2012). These cellular defects in infected 93 
macrophages are characteristic for B. cenocepacia and depend on T6SS-mediated defects 94 
in the activation of multiple Rho family GTPases by an unknown mechanism presumably 95 
via unknown T6SS effector molecules (Flannagan et al., 2012; Rosales-Reyes et al., 96 
2012). Here we show that Hcp detection in bacterial culture supernatants and 97 
quantification of the morphological phenotype in infected macrophages allowed us to 98 
characterize the components of the T6S apparatus in B. cenocepacia required for T6SS 99 
function and to refine the boundaries of the T6SS cluster. The relevance of B. 100 
cenocepacia VgrG proteins for T6SS function and T6SS-related phenotype was also 101 
investigated. From our results, we propose that quantification of the morphological 102 
phenotype in macrophages is a sensitive and reproducible test that can serve as a 103 
screening tool to identify mutations denoting B. cenocepacia genes that are responsible 104 
for disturbing the actin cytoskeleton in infected macrophages. 105 
106 
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 107 
METHODS 108 
Bacterial strains, plasmids, and culture media. Bacterial strains and plasmids used in 109 
this study are listed in Table 1. Bacteria were grown in Luria Broth (LB) (Difco) at 37oC. 110 
Escherichia coli cultures were supplemented, as required, with the following antibiotics 111 
(final concentrations): 30 μg tetracycline ml-1, 30 μg kanamycin ml-1, and 50 μg 112 
trimethoprim ml-1. B. cenocepacia cultures were supplemented, as required, with 100 μg 113 
trimethoprim ml-1 and 100 μg tetracycline ml-.  114 
 115 
General molecular techniques. DNA manipulations were performed as described 116 
previously (Sambrook et al., 1990). T4 DNA ligase (Roche Diagnostics, Laval, Quebec, 117 
Canada) and Antarctic phosphatase (New England Biolabs, Pickering, Ontario, Canada) 118 
were used as recommended by the manufacturers. Transformation of E. coli DH5α and E. 119 
coli GT115 was done using the calcium chloride method (Cohen et al., 1972). 120 
Mobilization of complementing plasmids and mutagenesis plasmids into B. cenocepacia 121 
was performed by triparental mating using E. coli DH5α carrying the helper plasmid 122 
pRK2013 (Craig et al., 1989; Figurski & Helinski, 1979). DNA amplification by 123 
polymerase chain reaction (PCR) was performed using a PTC-221 DNA engine (MJ 124 
Research, Incline Village, Nevada) with Taq or HotStar HiFidelity DNA polymerases 125 
(Qiagen Inc., Mississauga, Ontario, Canada). DNA sequences of all primers used in this 126 
study are described in the Supplemental Table S2. DNA sequencing was performed at the 127 
DNA sequencing Facility of York University, Toronto, Canada. The KEGG database 128 
(Kanehisa & Goto, 2000) and the computer program BLAST (Altschul et al., 1990) were 129 
used to analyze the sequenced genome of B. cenocepacia strains K56-2 and J2315. 130 
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 131 
Deletion mutagenesis of B. cenocepacia K56-2 and complementing plasmids. 132 
Oligonucleotide primers used for the construction of mutagenic and complementing 133 
plasmids are listed in Table S1, and the plasmids construction details are provided in 134 
Supplementary data. Unmarked and non-polar deletions were performed as described 135 
previously (Flannagan et al., 2008; Hamad et al., 2010). All deletion plasmids were 136 
introduced into E. coli GT115 by transformation and mobilized into B. cenocepacia by 137 
triparental mating. When gentamicin-sensitive strains were used, E. coli counter-selection 138 
was performed with 200 μg carbenicillin ml-1 and 10 μg polymyxin B ml-1 instead of 50 139 
μg gentamicin ml-1. Gene deletions were confirmed by PCR. Mutants were tested in a 140 
Bioscreen C automated microbiology growth curve analysis system at 37°C, with 141 
continuous shaking and OD600 measurements taken every hour as described previously 142 
(Aubert et al., 2008). 143 
 144 
Expression and purification of His-tagged Hcp and polyclonal antibody 145 
preparations. hcp was PCR amplified with primers 2143 and 2748 and cloned into 146 
plasmid pET30a using NdeI and HindIII restriction sites. This generated plasmid pDA44 147 
encoding Hcp6xHis, which was introduced into E. coli strain BL21 (DE3) by 148 
transformation. Overexpression of Hcp6xHis was performed as follows. E. coli cells were 149 
grown to an OD600 of 0.6, induced with 0.05 mM isopropyl-β-d-1-thiogalactopyranoside 150 
(IPTG), and grown for another 2 h at 30°C. Cells were collected by centrifugation and 151 
resuspended in 50 mM sodium phosphate pH 7.4, 300 mM NaCl, and lysed using a 152 
French press. Debris were removed following centrifugation at 20 000 ×g for 20 min. 153 
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Hcp6xHis was purified from filtered supernatant by FPLC (ÄKTA Basic instrument) using 154 
a 5 ml HisTrap column (GE Healthcare). Elution was performed using a linear gradient 155 
concentration of imidazole (10-400 mM). Fractions containing purified Hcp6xHis were 156 
pooled and dialyzed against 50 mM sodium phosphate, pH 7.4, 300 mM NaCl, and stored 157 
at 4°C. The eluted Hcp6xHis was judged >90 % pure after this step. Polyclonal antibodies 158 
recognizing Hcp were generated in New Zealand White rabbits by ProSci Inc. (Poway, 159 
CA). 160 
 161 
Precipitation of culture supernatant proteins and immunoblot analysis. Culture 162 
supernatant proteins were precipitated as described previously (Aubert et al., 2008) with 163 
some modifications. Briefly, overnight cultures were diluted to an OD600 of 0.03 in pre-164 
warmed LB and grown until early exponential phase, at which time OD600 was also 165 
recorded. Proteins from filter-sterilized culture supernatants were precipitated overnight 166 
at 4 °C using 20% trichloroacetic acid (final concentration). Five μg of secreted proteins 167 
were loaded on an 18% SDS-PAGE. The crude lysate sample (pellet fraction) was 168 
prepared as follows: bacteria from 1 ml of exponential phase culture adjusted at an OD600 169 
of 0.5 were pe170 
and boiled for 10 min. Samples were centrifuged for 3 min at 5 900 ×g 171 
cell lysate were loaded on a 18% SDS-PAGE. After electrophoresis, gels were transferred 172 
to nitrocellulose membranes for immunoblot analysis. After blocking (Roche), the 173 
membranes were incubated with the following primary antibodies as required. 4RA2 174 
monoclonal antibody (Neoclone), which cross-reacts with the B. cenocepacia and B. 175 
multivorans RNA polymerase subunit alpha (cytosolic / cell lysis control) (dilution of 176 
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1:25 000), anti-Hcp polyclonal antiserum (ProSci-inc) (dilution of 1:1 000) and FLAG 177 
M2 monoclonal antibody (Sigma) (dilution of 1:50 000). Secondary antibodies Alexa 178 
Fluor 680 conjugated goat anti-mouse IgG (Molecular Probes) and IRDye800 conjugated 179 
goat anti-rabbit IgG (Rockland) were used at a dilution of 1:50 000. Detection was 180 
performed using the Odyssey Infrared Imager (LI-COR Biosciences).  181 
 182 
Macrophage infections and quantification of the T6SS activity. Infections were 183 
performed as previously described (Aubert et al., 2008) using the C57BL/6 murine bone 184 
marrow-derived macrophage cell line ANA-1 (Cox et al., 1989). Bacteria were washed 185 
three times with DMEM 10% FBS and added to ANA-1 cells grown on glass coverslips 186 
at a MOI of 50:1. Plates were centrifuged for 2 min at 300 ×g to synchronize the infection 187 
and incubated at 37°C under 5% CO2. Coverslips were analyzed by phase contrast 188 
microscopy at 4 h post-infection. T6SS activity was recorded as the ability of the bacteria 189 
to induce the formation of characteristic ectopic structures around the macrophages 190 
(Aubert et al., 2008). An assay was developed to measure the extent of the formation of 191 
these structures around the macrophages. As “beads on a string-like” structures appear as 192 
dark objects on a clear background around macrophages in phase contrast microscopy the 193 
percentage of the area occupied by dark objects can be measured upon picture analysis 194 
using the Northern Eclipse software. For each infection, pictures with a 100x 195 
magnification were taken under the same conditions of light, gain and exposure. A 196 
threshold was applied to highlight the dark pixels on the images and the number of 197 
macrophages and Percent of object Area values for each image was recorded. The 198 
intensity of T6SS activity was calculated for each mutant by dividing the sum of the 199 
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Percent Area values measured over at least 21 fields of view by the total number of 200 
macrophages (over 300 macrophages). The ability to induce the formation of “beads on a 201 
string-like” structures around macrophages, which is representative of the T6SS activity 202 
in each mutant, was expressed in arbitrary units relative to ΔatsR set as 1. Experiments 203 
were repeated independently three times. Uninfected ANA-1 cells were used as a 204 
negative control to determine background levels. The negative control had 0.1±0.02 205 
relative units. Therefore, experimental samples giving relative units equal or lower than 206 
0.2 (corresponding to 5 standard deviation units from the mean of the negative control) 207 
were considered as indicative of cells lacking ectopic structures. One-way Anova (Prism 208 
5.0a, GraphPad Software Inc.) was utilized to analyze the data from the quantification 209 
experiments. The Bonferroni Multiple Comparison test using a significance level of 0.01 210 
was used to compare the relative units obtained from experimental samples and 211 
uninfected controls.  212 
 213 
Gentamicin protection assay. Bacterial infection and bacterial intracellular survival 214 
were assayed as described previously (Schmerk & Valvano, 2013) with slight 215 
modifications. ANA-1 macrophages were seeded in 12-well plates at a density of 3x105 216 
cells per well and incubated overnight. Gentamicin sensitive strains were grown 217 
overnight in LB broth at 37°C with shaking. Bacteria were used to infect ANA-1 218 
macrophages at a MOI of 50:1 as described above. One hour post-infection, macrophages 219 
were washed with PBS three times to remove extracellular bacteria. DMEM 10% FBS 220 
containing 100 µg gentamicin ml-1 was added to kill remaining extracellular bacteria. 221 
One hour later, macrophages were washed twice in PBS, and fresh medium containing 10 222 
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µg gentamicin ml-1 was added for the remainder of the experiment. To enumerate 223 
intracellular bacteria, infected macrophages were lysed with 0.1% sodium deoxycholate 224 
(w/v) at 4 h post-infection. Lysates were serially diluted in PBS and plated on LB agar. 225 
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 226 
RESULTS 227 
 228 
Functional characterization of the T6SS components of B. cenocepacia K56-2 229 
The genome of B. cenocepacia K56-2 contains only one T6SS locus on chromosome 1 230 
(spanning 23.7 kilobase pairs) (Fig. 1a). The boundaries of the T6SS locus in B. 231 
cenocepacia K56-2 were initially set from BCAL0352 up to BCAL0333 because of its 232 
immediate location upstream of a tRNA sequence (as observed in pathogenicity islands) 233 
and based on the identification of three putative transcriptional units containing 234 
conserved T6SS components (Aubert et al., 2010; Boyer et al., 2009). Unlike many other 235 
bacteria (Boyer et al., 2009), the putative T6SS cluster of B. cenocepacia K56-2 does not 236 
contain any vgrG (Fig. 1a). The predicted functions of the T6SS genes are listed in the 237 
Supplemental Table S2, and whenever possible the genes were named according to the 238 
proposed standard nomenclature for T6SS core components, tss (for T6SS gene) or tag 239 
(T6SS-associated gene) (Shalom et al., 2007). Each of the genes in the T6SS cluster was 240 
systematically deleted in B. cenocepacia ΔatsR and the mutants investigated for T6SS 241 
related phenotypes. All mutants had similar growth rates compared to the wild type strain 242 
(data not shown). As previously demonstrated (Aubert et al., 2008), infection of ANA-1 243 
macrophages with ΔatsR induces the formation of “beads on a string-like” structures due 244 
to lamellipodia collapse and impairment of actin-tail retraction during macrophage 245 
migration (Flannagan et al., 2012; Rosales-Reyes et al., 2012) (Fig. 1b). This phenotype 246 
depends on a functional T6SS, as ΔatsRΔhcp cannot disturb the cytoskeleton 247 
organization (Aubert et al., 2008; Rosales-Reyes et al., 2012). The nature of the secreted 248 
 13 
effector eliciting changes in actin architecture is still unknown. In an attempt to determine 249 
whether a gene encoding an effector lied within the T6SS cluster, mutants were first 250 
evaluated for their ability to induce cytoskeletal rearrangements in infected macrophages 251 
and then for their ability to release Hcp into culture supernatants (denoting a functional 252 
T6SS). An assay was developed to quantify the T6SS activity by measuring the extent of 253 
the formation of “beads on a string-like” structures. Since these structures appear around 254 
macrophages as dark objects on a clear background in phase contrast microscopy (Fig. 255 
1b) it is possible to measure the area they occupy per field of view using image analysis 256 
software. The “amount” of dark objects, which is representative of the intensity of T6SS 257 
activity, was calculated (see Methods) for each mutant tested and expressed relative to 258 
ΔatsR (Fig. 1c). Uninfected cells were used as negative control to determine the 259 
background level. Relative units below 0.2 (corresponding to 5 standard deviation units 260 
from the mean) were considered as indicative of cells lacking ectopic structures and 261 
consequently infected with T6SS-defective strains. 262 
 263 
Deletion mutants lacking tssM (BCAL0351; icmF-like), tssA (BCAL0348), tssH 264 
(BCAL0347; clpV-like), tssG (BCAL0346), tssF (BCAL0345), tssE (BCAL0344), tssD 265 
(BCAL0343; hcp-like), tssC (BCAL0342; bcsKC), tssB (BCAL0341; bcsLB), tssK 266 
(BCAL0338) or tssL (BCAL0337) did not produce visible ectopic structures around 267 
macrophages. Therefore, the calculated relative units were not significantly different than 268 
those of uninfected cells, indicating that the deleted genes encode critical components for 269 
the T6SS activity (Fig. 1c). The mutant with a deletion of BCAL0340 was able to induce 270 
the formation of ectopic structures around macrophages at very low levels (0.27 ± 0.02 271 
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relative units), but the results did not show a significant difference compared to 272 
uninfected cells. In contrast, mutants carrying a deletion in BCAL0352, tagF 273 
(BCAL0350), tagL (BCAL0349), tssJ (BCAL0339), and BCAL0336-33 were able to 274 
induce the formation of ectopic structures around macrophages, resulting in significantly 275 
different relative units compared to the uninfected control (p < 0.001), suggesting that 276 
these genes encode proteins dispensable for T6SS activity under the conditions assayed 277 
here. 278 
 279 
Mutants were also evaluated for their ability to export and release Hcp into culture 280 
supernatants. As previously demonstrated (Aubert et al., 2010; Aubert et al., 2008), Hcp 281 
is clearly detected in culture supernatants from ΔatsR denoting a functional T6S 282 
machinery (Fig. 1d). Most of the genes located within the T6SS cluster were required for 283 
Hcp export. Mutants carrying a deletion in tssM, tssA, tssH, tssG, tssF, tssE, tssC, tssB, 284 
BCAL0340, tssK or tssL were unable to export Hcp, while mutants with a deletion in 285 
BCAL0352, tagL or tssJ had reduced levels of Hcp exported into the culture supernatants 286 
as compared to ΔatsR. These results also agree with the observation that these three 287 
mutants reproducibly induced lower levels of ectopic structures in macrophages in 288 
comparison with ΔatsR (0.71, 0.72, and 0.55 relative units; Fig. 1c), suggesting that the 289 
encoded proteins probably have an effect on the overall efficiency of the T6SS. In 290 
contrast, similar levels of Hcp were detected in ΔatsRΔBCAL0336-33 and ΔatsR culture 291 
supernatants. Besides ΔatsRΔhcp, the intracellular levels of Hcp were similar for all 292 
mutants tested except for ΔatsRΔtagF, which repeatedly displayed lower levels of 293 
cytosolic Hcp but higher levels of exported Hcp compared to ΔatsR (Fig. 1d).  294 
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 295 
These results show that there is in most cases, a good correlation between Hcp export 296 
levels and T6SS activity as measured by the extent of the formation of “beads on a string-297 
like” structures. Together, these assays identified tssM, tssA, tssH, tssG, tssF, tssE, 298 
tssD(hcp), tssC, tssB, BCAL0340, tssK and tssL as core components of the T6S 299 
machinery, which are critical for assembly and function, and BCAL0352, tagL and tssJ 300 
as accessory proteins likely involved in the stability of the T6SS complex or required for 301 
its proper functioning. None of the mutants tested were unable to elicit changes in 302 
macrophages morphology while retaining the ability to export Hcp, suggesting that the 303 
gene encoding the effector molecule responsible for cytoskeletal rearrangements is not 304 
located within the T6SS cluster. 305 
 306 
Characterization of BCAL0345 paralogs 307 
We investigated the presence of paralogs of the T6SS genes using the KEGG database for 308 
the B. cenocepacia strain J2315 (http://www.genome.jp/kegg-309 
bin/show_organism?org=bcj), which is a clonal isolate with K56-2 (Mahenthiralingam et 310 
al., 2000). For each gene of the T6SS, paralogs were investigated according to the 311 
threshold values given for the Smith-Waterman algorithm (Smith & Waterman, 1981), as 312 
automatically provided by the KEGG database. We found that the genes located in the 313 
T6SS locus were unique within B. cenocepacia except for tssF and tssH. Each of them 314 
has two paralogs BCAL1293/BCAS0668 (in chromosome 3) and 315 
BCAL1919/BCAL2730, respectively. BCAL1919 and BCAL2730 were not further 316 
investigated as they encode the well-characterized ClpB heat-shock protein and ATP-317 
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binding subunit ClpA from the ATP-dependent Clp protease, respectively. Interestingly, 318 
BCAL1293 and BCAS0668 were located immediately next to a VgrG encoding gene 319 
(BCAL1294 and BCAS0667). The amino acid sequences of BCAL1293 and BCAS0668 320 
are 42% and 40% identical (58% and 54% similar) to TssF, respectively (Fig. S1). 321 
BCAL1293 and BCAS0668 were individually deleted in ΔatsR and mutants were tested 322 
for T6SS activity in our macrophage infection model. In contrast to ΔatsRΔtssF, 323 
ΔatsRΔBCAL1293 and ΔatsRΔBCAS0668 could elicit morphological changes in 324 
macrophages at similar levels to ΔatsR (Fig. 2). Introduction of plasmid pL0345 325 
(encoding TssF) into ΔatsRΔBCAL0345 restored T6SS activity, however introduction of 326 
plasmids pL1293 or pS0668 (expressing BCAL1293 or BCAS0668, respectively) did not 327 
(Fig. 2). These results suggest that although BCAL1293 or BCAS0668 are paralogs of 328 
the critical core component TssF, they are not required for T6SS activity under the 329 
conditions assayed here, as they cannot functionally replace TssF. 330 
 331 
Identification and characterization of the VgrGs of B. cenocepacia K56-2 332 
The N-terminus of a VgrG element contains two conserved domains, Phage_GPD and 333 
Phage_base_V (former DUF586), which are related to the bacteriophage T4 tail spike 334 
protein gp27 (Pukatzki et al., 2007). Computer-assisted analysis using the sequence of 335 
the Phage_base_V motif from VgrG2 (VCA0018 from V. cholerae) as query identified 336 
ten VgrGs (BCAL1165, BCAL1294, BCAL1355, BCAL1359, BCAL1362, BCAL2279, 337 
BCAM0043, BCAM0148, BCAM2254, and BCAS0667) in the sequenced genome of B. 338 
cenocepacia K56-2 (Varga et al., 2013)(GenBank accession number 339 
NZ_ALJA00000000.2) (Fig. 3). The vgrGs were scattered over the three chromosomes 340 
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and none of them was localized in or at the vicinity of the T6SS cluster. BCAM2279 has 341 
an insertion sequence (IS) inserted at the very end of the gene; however, the encoded 342 
VgrG might still be functional since only the last 17 amino acids are missing and 343 
replaced by 22 amino acids provided by the IS, which are followed by a stop codon. Psi-344 
BLAST and PFAM analysis revealed that these VgrGs also contains the Phage_GPD 345 
domain and other motifs classically found in VgrG proteins such as T6SS_Vgr, Gp5_C 346 
repeats and DUF2345 (Fig. 3). None of them displayed C-terminal extensions with 347 
homologies to domains found in previously characterized “evolved” VgrGs (e.g. actin-348 
crosslinking domain, ADP-ribosylation domain, peptidoglycan-binding domain). Instead, 349 
conserved domain predictions identified a C-terminal extension in the two largest VgrGs, 350 
BCAL1359 (1233 aa) and BCAS0667 (999 aa), which carry a M6 family metalloprotease 351 
domain with a characteristic HExxH motif (E-value: 7.18e-03) and a putative lipase_3 352 
domain (GxSxG motif, E-value: 2.8e-02) found in triglyceride lipase, respectively. 353 
 354 
Each vgrG gene was individually deleted in B. cenocepacia ΔatsR and growth curves 355 
analyses indicated that all mutants had similar growth rates (data not shown). Mutants 356 
were then tested for their ability to induce cytoskeleton rearrangements in infected 357 
macrophages and to export Hcp into culture supernatants (Fig. 4a-b). Single vgrG 358 
deletions did not affect either Hcp export or morphological changes in macrophages 359 
denoting T6SS activity, suggesting that none of the individual VgrGs are critical for 360 
T6SS function. Although we cannot rule out that the evolved VgrGs BCAL1359 and 361 
BCAS0667 are T6SS effectors, they can be excluded from an involvement in actin 362 
cytoskeleton alterations. A VgrG-less strain was created in B. cenocepacia ΔatsR. 363 
 18 
Deletion of the 10 vgrG genes resulted in a non-functional T6SS unable to cause the actin 364 
cytoskeleton phenotype in infected macrophages or export Hcp (Fig. 4c), indicating that 365 
multiple VgrGs are nevertheless required for the changes in macrophage morphology that 366 
are characteristics of B. cenocepacia T6SS function.  367 
368 
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DISCUSSION 369 
This study aimed to characterize the B. cenocepacia T6SS using two assays indicative of 370 
T6SS function: Hcp secretion and quantification of the morphological defects in infected 371 
macrophages. Deletion of most genes in the B. cenocepacia T6SS cluster resulted in 372 
strains unable to export Hcp. These results were not surprising since with the exception 373 
of BCAL0340, orthologs of all the genes annotated as critical components in our study 374 
were also identified as genes encoding conserved core subunits essential for the T6 375 
secretory functions in other bacteria (Durand et al., 2012; English et al., 2014; Zheng & 376 
Leung, 2007; Zheng et al., 2011; Zoued et al., 2013). However, one major difference 377 
concerned the tssJ-like BCAL0339. In enteroaggregative E. coli, V. cholerae and 378 
Edwardsiella tarda, tssJ encodes an outer membrane lipoprotein that interacts with TssM 379 
and is critical for Hcp export (Aschtgen et al., 2008; Felisberto-Rodrigues et al., 2011; 380 
Zheng & Leung, 2007; Zheng et al., 2011). In B. cenocepacia, TssJBc is not essential, 381 
although it is required for optimum Hcp export and T6SS activity. While this remains to 382 
be tested, it is possible that an additional component encoded within the B. cenocepacia 383 
T6SS cluster exerts a function similar to that of TssJBc. BCAL0340 (NOG73587) could 384 
be such a candidate. Like TssJBc, BCAL0340 is predicted to be a lipoprotein, and 385 
contains tetratricopeptide repeats indicating that it is likely involved in protein-protein 386 
interaction. BCAL0340 is highly conserved among the T6SS clusters in Burkholderia 387 
species but infrequently found in T6SS clusters from other bacteria (Boyer et al., 2009). 388 
It is also absent from the T6SS clusters from enteroaggregative E. coli, V. cholerae and 389 
Edwardsiella tarda. In contrast to TssJBc, our results demonstrate that BCAL0340 is a 390 
critical component of the B. cenocepacia T6SS, since deletion of BCAL0340 abolished 391 
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Hcp export and also prevented the "beads on a string" phenotype in infected 392 
macrophages.  393 
 394 
Like BCAL0340, BCAL0352 is another gene not frequently found within T6SS clusters 395 
(Boyer et al., 2009), and it is also highly conserved among the T6SS clusters of 396 
Burkholderia species. BCAL0352 (NOG43466) encodes a putative membrane anchored 397 
M15C metallopeptidase possibly with L-alanyl-D-glutamate endopeptidase activity, 398 
which suggests an involvement in peptidoglycan degradation that is reminiscent of the 399 
Tse toxins involved in bacterial competition (Russell et al., 2011). However, the effect of 400 
BCAL0352 deletion on Hcp export, the presence of a N-terminal signal peptide and one 401 
transmembrane domain in the encoded protein argue against a putative effector role. 402 
Although previous data in our laboratory indicated that BCAL0352 and BCAL0351 are 403 
co-transcribed (Aubert & Valvano, unpublished), it is also possible that deletion of 404 
BCAL0352 affects additional promoter sequences required for optimum T6SS 405 
expression.  406 
 407 
TagF (BCAL0350) is conserved in 30% of the identified T6SS clusters (Boyer et al., 408 
2009), but it was dispensable for T6SS activity in B. cenocepacia. Interestingly, deletion 409 
of tagF led to decreased endogenous Hcp pool and a corresponding increase in Hcp 410 
release into culture supernatants. These observations suggest that TagF might have a role 411 
in the turnover of the Hcp channel. TagL (BCAL0349) is conserved in 25% of the T6SS 412 
clusters (Boyer et al., 2009) and encodes a putative outer membrane protein with an 413 
OmpA motif (E value 4.4e-25) and the PF0691 motif, which is characteristic of cell wall 414 
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binding protein components of T6SSs (Aschtgen et al., 2010). TagL may have an 415 
accessory function, which can be important for the proper production, assembly, or 416 
activity of the T6S apparatus. Further, our results ruled out the small ORFs (BCAL0333-417 
BCAL0336) as genes encoding either potential T6SS effectors involved in the eukaryotic 418 
phenotype or components influencing T6SS functioning. Therefore, we have reassigned 419 
the boundaries of the B. cenocepacia T6SS cluster to only include 16 genes (BCAL0352-420 
tssL)(Fig. 1a). 421 
 422 
Individual deletion of any of the 10 VgrGs identified in B. cenocepacia K56-2 did not 423 
alter Hcp export or the ability of the mutant strain to produce morphological changes in 424 
macrophages, suggesting these proteins have redundant function. Whether the two VgrGs 425 
with a C-terminal extension (BCAL1359 and BCAS0667) are effectors involved in other 426 
T6SS functions such as bacterial competition will require additional experimentation. 427 
VgrGs are also structural components of the T6S machinery and as part of the base-plate 428 
complex they are required for the initiation of the Hcp tube polymerization (Basler et al., 429 
2012). As expected, deletion of the 10 vgrGs in ΔatsR abolished Hcp export and T6SS 430 
activity. Although the effect of successive vgrG deletions was not investigated, these 431 
results confirm that at least several of the B. cenocepacia VgrGs are critical for the T6SS 432 
function. Most of the 10 VgrGs likely have redundant functions, suggesting their 433 
relevance in T6SS assembly presumably depends on their nature and relative expression 434 
levels. In summary, we have characterized core components of the B. cenocepacia T6SS. 435 
Our results indicate that none of these components are directly responsible for inducing 436 
actin cytoskeletal changes in macrophages. However, the quantitative approach we have 437 
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developed to investigate macrophage cell morphology can be adapted for screening 438 
random mutants in the search for one or more T6SS effector proteins acting on Rho-type 439 
GTPases, which is currently underway in our laboratory.  440 
 441 
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 702 
Table 1. Strains and plasmids 703 
 704 
Strain or plasmid Relevant characteristicsa Source and/or reference 705 
 706 
B. cenocepacia    707 
K56-2      ET12 clone related to J2315, CF clinical Isolate  bBCRRC, (Mahenthiralingam et al., 708 
2000) 709 
K56-2 atsR     Deletion of atsR in K56-2    (Aubert et al., 2010) 710 
K56-2 atsR GmS      Deletion of BCAL1674-76 in K56-2 atsR - GmS This study 711 
K56-2 atsR BCAL1165    Deletion of BCAL1165 in K56-2 atsR  This study 712 
K56-2 atsR BCAL1293    Deletion of BCAL1293 in K56-2 atsR  This study 713 
K56-2 atsR BCAL1294    Deletion of BCAL1294 in K56-2 atsR  This study 714 
K56-2 atsR BCAL1355    Deletion of BCAL1355 in K56-2 atsR  This study 715 
K56-2 atsR BCAL1359    Deletion of BCAL1359 in K56-2 atsR  This study 716 
K56-2 atsR BCAL1362    Deletion of BCAL1362 in K56-2 atsR  This study 717 
K56-2 atsR BCAL2279    Deletion of BCAL2279in K56-2 atsR  This study 718 
K56-2 atsR BCAM0043    Deletion of BCAM0043 in K56-2 atsR  This study 719 
K56-2 atsR BCAM0148    Deletion of BCAM0148 in K56-2 atsR  This study 720 
K56-2 atsR BCAM2254    Deletion of BCAM2254 in K56-2 atsR  This study 721 
K56-2 atsR BCAS0667     Deletion of BCAS0667 in K56-2 atsR  This study 722 
K56-2 atsR BCAS0668     Deletion of BCAS0668 in K56-2 atsR  This study 723 
K56-2 atsR BCAL0352    Deletion of BCAL0352 in K56-2 atsR  This study 724 
K56-2 atsR BCAL0351    Deletion of BCAL0351 in K56-2 atsR  This study 725 
K56-2 atsR BCAL0350    Deletion of BCAL0350 in K56-2 atsR  This study 726 
K56-2 atsR BCAL0349    Deletion of BCAL0349 in K56-2 atsR  This study 727 
K56-2 atsR BCAL0348    Deletion of BCAL0348 (bcsE) in K56-2 atsR  (Aubert et al., 2010) 728 
K56-2 atsR BCAL0347    Deletion of BCAL0347 (bcsF) in K56-2 atsR  (Aubert et al., 2010) 729 
K56-2 atsR BCAL0346    Deletion of BCAL0346 (bcsG) in K56-2 atsR  (Aubert et al., 2010) 730 
K56-2 atsR BCAL0345    Deletion of BCAL0345 (bcsH) in K56-2 atsR  (Aubert et al., 2010) 731 
K56-2 atsR BCAL0344     Deletion of BCAL0344 (bcsI) in K56-2 atsR  (Aubert et al., 2010) 732 
K56-2 atsR hcp      Deletion of BCAL0343 in K56-2 atsR  (Aubert et al., 2010) 733 
K56-2 atsR BCAL0342    Deletion of BCAL0342 (bcsK) in K56-2 atsR  (Aubert et al., 2010) 734 
K56-2 atsR BCAL0341     Deletion of BCAL0341 (bcsL) in K56-2 atsR  (Aubert et al., 2010) 735 
K56-2 atsR BCAL0340    Deletion of BCAL0340 (bcsM) in K56-2 atsR  (Aubert et al., 2010) 736 
K56-2 atsR BCAL0339    Deletion of BCAL0339 in K56-2 atsR  This study 737 
K56-2 atsR BCAL0338    Deletion of BCAL0338 in K56-2 atsR  This study 738 
K56-2 atsR BCAL0339    Deletion of BCAL0337 in K56-2 atsR  This study 739 
K56-2 atsR BCAL0336-33  Deletion of BCAL0336-0333 in K56-2 atsR  This study 740 
K56-2 atsR 10vgrGs    Deletion of BCAL1165, 1294, 1355, 1359, 1362, 2279,  741 
      BCAM0043, 0148, 2254 and BCAS0667  742 
      in K56-2 atsR  - VgrG-less strain   This study   743 
 744 
E. coli   745 
BL21 (DE3)     F- ompT hsdSB(rB- mB-) gal dcm(λDE3)  Laboratory stock 746 
DH5α      F- 80lacZ M15 endA1 recA1 supE44 hsdR17(rK- mK+) deoR Laboratory stock 747 
      thi-1 nupG supE44 gyrA96 relA1 ∆(lacZYA-argF)U169, λ– 748 
GT115      F– mcrA ∆(mrr-hsdRMS-mcrBC) 80∆lacZ∆M15 ∆lacX74  Invivogen 749 
   recA1 rpsL (StrA) endA1∆dcm uidA(∆MluI)::pir-116  750 
   ∆sbcC-sbcD  751 
 752 
  753 
Plasmids     754 
pL0345      BCAL0345 cloned into pDA12   This study 755 
pL1293      BCAL1293 cloned into pDA12   This study 756 
pS0668      BCAS0668 cloned into pDA12   This study 757 
pDA12      cloning vector, oripBBR1, TetR, mob+, Pdhfr  (Aubert et al., 2008) 758 
pDA44      hcp6xHis cloned into pET30a    This study 759 
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pDAI-SceI-SacB     oripBBR1, TetR, Pdhfr, mob+, expressing I-SceI, SacB (Hamad et al., 2010) 760 
pDelL0352     pGPI-SceI with fragments flanking BCAL0352  This study 761 
pDelL0351      pGPI-SceI with fragments flanking BCAL0351  This study  762 
pDelL0350     pGPI-SceI with fragments flanking BCAL0350  This study 763 
pDelL0349     pGPI-SceI with fragments flanking BCAL0349  This study 764 
pDelL0339     pGPI-SceI with fragments flanking BCAL0339  This study 765 
pDelL0338     pGPI-SceI with fragments flanking BCAL0338  This study 766 
pDelL0337     pGPI-SceI with fragments flanking BCAL0337  This study 767 
pDelL0036-33     pGPI-SceI with fragments flanking BCAL0336-0333 This study 768 
pDelL1165      pGPI-SceI with fragments flanking BCAL1165  This study 769 
pDelL1293     pGPI-SceI with fragments flanking BCAL1293  This study 770 
pDelL1294     pGPI-SceI with fragments flanking BCAL1294  This study 771 
pDelL1355     pGPI-SceI with fragments flanking BCAL1355  This study 772 
pDelL1359     pGPI-SceI with fragments flanking BCAL1359  This study 773 
pDelL1362     pGPI-SceI with fragments flanking BCAL1362  This study 774 
pDelL2279     pGPI-SceI with fragments flanking BCAL2279  This study 775 
pDelM0043     pGPI-SceI with fragments flanking BCAM0043 This study 776 
pDelM0148     pGPI-SceI with fragments flanking BCAM0148 This study 777 
pDelM1857     pGPI-SceI with fragments flanking BCAM1857 This study 778 
pDelM2254     pGPI-SceI with fragments flanking BCAM2254 This study 779 
pDelS0667     pGPI-SceI with fragments flanking BCAS0667  This study 780 
pDelS0668     pGPI-SceI with fragments flanking BCAS0668  This study 781 
pET30a      Expression vector, KanR    Novagen 782 
pGPI-SceI     oriR6K,  R , mob+, including an I-SceI restriction site  (Flannagan et al., 2008) 783 
pMH447      pGPI-SceI with fragments flanking BCAL1674-1676 (Hamad et al., 2010) 784 
pRK2013         oricolE1, RK2 derivative, KanR, mob+, tra+  (Figurski & Helinski, 1979) 785 
 786 
a GmS, gentamicin sensitive, KanR, kanamycin resistance, TetR, tetracycline resistance, TpR, trimethoprim resistance. 787 
b BCRRC, B. cepacia Research and Referral Repository for Canadian CF Clinics.788 
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FIGURE LEGENDS 790 
 791 
Fig.1. Investigation of the B. cenocepacia T6SS gene cluster. (a) Genetic map of the B. 792 
cenocepacia K56-2 T6SS gene cluster. The arrows represent the location and direction of 793 
transcription of each gene. The “BCAL” locus tags assigned by the Sanger Center are 794 
shown above and the standard tss or tag annotation of the genes (listed in Supplemental 795 
Table S2) is shown below. White, grey and black arrows represent the critical 796 
components, accessory proteins and dispensable elements for T6SS activity identified in 797 
this study, respectively. The genes encoding the well-characterized components IcmF 798 
(BCAL0351; TssMBc), ClpV (BCAL0347; TssHBc), and Hcp (BCAL0343; TssDBc) and 799 
location of the tRNA threonine (tRNA-Thr) sequence are shown. (b) Phase-contrast 800 
microscopy of infected ANA-1 macrophages and qualitative assessment of T6SS activity. 801 
The infections were performed at an MOI of 50:1 for 4 h. The presence of ectopic 802 
structures is indicative of expression and functionality of the T6SS. Characteristic ‘beads’ 803 
surrounding infected macrophages are shown by white arrows. Infections were repeated 804 
independently and reproducible results were obtained. The pictures shown are 805 
representatives. (c) Measurement of T6SS activity. The proportion of dark “beads on a 806 
string-like” structures around macrophages was measured using image analysis software. 807 
Results were expressed in arbitrary units relative to ΔatsR set as 1 (white bar). Values are 808 
mean ± standard deviation for at least 21 fields of view and are representative of three 809 
independent experiments. Uninfected cells were used as negative control to determine the 810 
background level. The dotted line indicates the 0.2 relative units threshold indicative of 811 
no “beads on a string-like” structures. ***, p < 0.001 compared to the relative units of 812 
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uninfected cells (see Methods for details on the statistical analysis). (d) Western blot 813 
analysis of total cell lysates (Pellet) and concentrated culture supernatants recovered from 814 
ΔatsR and T6SS mutants using anti-RNAP α subunit (cytosolic protein, cell lysis control) 815 
and anti-Hcp antibodies. The upper band seen in the pellet fractions with the anti-Hcp 816 
antibody corresponds to a cross-reacting unspecific protein. 817 
 818 
Fig.2. Investigation of the tssF (BCAL0345) paralogs. Phase-contrast microscopy of 819 
infected ANA-1 macrophages and qualitative assessment of T6SS activity. The infections 820 
were performed at an MOI of 50:1 for 4 h with B. cenocepacia K56-2 ΔatsR, derivative 821 
mutants in tssF or paralogs (BCAL1293 and BCAS0668) and mutants carrying plasmids 822 
pL0345, pL1293 or pS0668, which express TssF, BCAL1293 and BCAS0668, 823 
respectively. Formation of ectopic structures indicates T6SS functionality. Infections 824 
were repeated independently and reproducible results were obtained. The pictures shown 825 
are representatives. 826 
 827 
Fig. 3. Putative conserved domains detected within the VgrGs of B. cenocepacia K56-2. 828 
Conserved domains within VgrGs were detected using PFAM search 829 
(http://pfam.sanger.ac.uk). The VgrG2 (VCA0018) from Vibrio cholerae was used as 830 
query to identify the VgrGs from B. cenocepacia K56-2 and is shown here for 831 
comparison. Domains are as follows: Phage_GPD (green), Phage_base_V (red), 832 
T6SS_Vgr (blue), DUF2345 (yellow). The putative effector domains found at the C-833 
terminus of BCAL1359 and BCAS0667 are represented with a grey (M6 family 834 
metalloprotease domain) and brown (lipase_3 domain) circle, respectively. 835 
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 836 
Fig. 4. Investigation of the B. cenocepacia VgrGs. (a) Measurement of T6SS activity. 837 
The infections were performed at an MOI of 50:1 for 4 h with B. cenocepacia K56-2 838 
ΔatsR and derivative vgrG mutants. The proportion of dark “beads on a string-like” 839 
structures around macrophages was measured as described in Methods and in the Fig. 1 840 
legend. The dotted line indicates the 0.2 relative units threshold indicative of no “beads 841 
on a string-like” structures. All the single vgrG deletion strains induced “beads on a 842 
string-like” structures at a similar level as ΔatsR (no statistically significant differences) 843 
and significantly different levels (p < 0.001) from uninfected cells. (b) and (c) Western 844 
blot analysis of total cell lysates (Pellet) and concentrated culture supernatants recovered 845 
from B. cenocepacia K56-2 ΔatsR, ΔatsRΔhcp, vgrG mutants and from the vgrG-less 846 
strain K56-2 ΔatsRΔ10vgrGs using anti-RNAP α subunit (cytosolic protein, cell lysis 847 
control) and anti-Hcp antibodies. 848 
 849 
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Table S1  
 
Oligonucleotide primers 
Primer No. 5’-3’ Primer sequence Restriction enzyme* 
430 TGTGGCTGCACTTGAACG N/A 
2143 AGTCGAAGGCATATGTTACACATGCACTTGCAG NdeI 
2748 TCGAAAGCTTGACCGCGTAGGTCTTGTCGT HindIII 
2863 TTTACCCGGGTCTTGACAGGGACGATTTCC SmaI 
2867 TACGTCTAGAATGAGCTCAAGCGGCTGT XbaI 
3059 TTTTTCTAGAAGATACGCAACGGCGATAAC XbaI 
3065 TTTTCTCGAGATTGCTCTGGAGCTGGAAGA XhoI 
3066 TTTTCTCGAGATTGAGTTGCGAACCGGTAA XhoI 
3068 TTTTGAATTCGCAGTCCTTTGTCGATGACC EcoRI 
3077 TAGGTACCATTCACAAGAAGGATTCGA KpnI 
3080 TAGGTACCTTAGGCCACACGTTCAAG KpnI 
3177 TTAACTCGAGCGACGTCTTGATCGTCTTCA XhoI 
3201 GCTACGGTCTCGAGAAGCTG XhoI 
3202 AAAAGAATTCAGCCGAGAAACGCGAAAT EcoRI 
3203 TTTTTCTAGAATCTCACAGCGTCCTTTCGT XbaI 
3263 TTTACTCGAGTCGATGGTGAGAGCGTGAC XhoI 
3267 ATTACTCGAGATTCGGGGCGAAACTCAT XhoI 
3349 TTTATCTAGAAGGACGATGAAGGGTTTGGT XbaI 
3354 TAATCTCGAGATTGAATGCGCCAAAAAGAG XhoI 
3454 TTTTTCTAGAGGCGACGATGAACAGAATG XbaI 
3457 TTTTGAATTCGCCGGTTTAGTATCGGACAG EcoRI 
3458 TTTTCTCGAGCGTGTCGTCGTACTGGAACA XhoI 
3465 TTTTCTCGAGTACCAGTTGTACGGCCAGGT XhoI 
3759 TTTTTCTAGACGTCGCCTCTCTATTGCTCT XbaI 
3760 TTTTGCGGCCGCATGCGGGATCAAGACGTTAC NotI 
3761 AAAAGCGGCCGCGCGAATCAGGGGTTTCAGTA NotI 
3762 AAAAGAATTCTCAAATACCCGCTCCTCATC EcoRI 
3800 AAAAGAATTCGTTGGCATGTGACTGTCTGG EcoRI 
3801 AAAACTCGAGAGCTTAACCACGAAGCGAAA XhoI 
3947 TTTTCTCGAGTAGCGAATCATGGACGATCT XhoI 
3948 TTTTTCTAGATGTTGAACACTTCCGCAGTC XbaI 
4125 TAATGAATTCCCGTGTCGATGAAATTGATG EcoRI 
4126 TAATGCGGCCGCAAAACGGGGTTCGAATGAAT NotI 
4127 TTTAGCGGCCGCGCGTCGCATACGTTCATCG NotI 
4128 TTTTTCTAGAATCACGCTCTCCATCTGCTC XbaI 
4134 TTTTGAATTCCTGAGATCACACGCAAGGAA EcoRI 
4135 TTTTCTCGAGGACGTAGCCGTCGAAGTAGC XhoI 
4136 TTTTCTCGAGCTGGAAGCCAAGGAACTCTG XhoI 
4137 TTTTTCTAGAAGGTGAGCATCAGGACAACC XbaI 
4185 AAAACTCGAGGGTCAGTGTGCTCGACAAG XhoI 
4186 AAAATCTAGAATGCCAGCGCCTTCATATAG XbaI 
4305 TTTTGAATTCGCCGACTTCGAAAGAAAGTG EcoRI 
4306 TTTTGCGGCCGCTCAGCTGGTAGCAGGTCAAC NotI 
4308 TTTTGCGGCCGCAACCTGAGCCGAGTCTTCAA NotI 
4309 TTTTTCTAGAACCGCCCCAGTAATTCTTCT XbaI 
4893 TTTTGAATTCAATTGCCGAGGTTCACAATC EcoRI 
4894 TTTTCTCGAGGCTACGTTCAACTCGTCGTG XhoI 
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4895 TTTTCTCGAGCAAGCAGTCCGACTTCACGTT XhoI 
4896 TAATTCTAGATACATCGCAAAACCACCATC XbaI 
4897 TTTTTTCATATGTGAATATTGCAGCGAATG NdeI 
4898 TTTTTCTAGACTATCTCCACTGACCTATAC XbaI 
4899 TTTTGAATTCCCTTTATTTTCGTCTCAGG EcoRI 
4900 TTTTCTCGAGGCGTTCGTCCAAGGATTG XhoI 
4901 TTTTCTCGAGCGAGTGCTCACCTGACATTGC XhoI 
4902 TTTATCTAGAATGCCGAGAAGTTTCGAGAG XbaI 
4903 TATATTCATATGGCGTGACCGTCTGAAACG NdeI 
4904 TTTTTCTAGACTCTTCCGTCACCAGTCA XbaI 
4905 AAAAAACATATGGCAGGAAATATTGAGGTTC NdeI 
4906 AAAATCTAGAACTACGCCAGGATCGATTC XbaI 
5015 TTATCTCGAGCAGTTTCCCGAAAAGGTCTG XhoI 
5016 TTATGAATTCGAGACGCACCAGAAATGCTT EcoRI 
5017 TTTTGAATTCTGGAACCACAACCAGATCAA EcoRI 
5018 TTTTCTCGAGATGCGGCAACTAGATCCAT XhoI 
5019 TTTTCTCGAGACATCAACTCGCGACATCTG XhoI 
5020 TTTTTCTAGAGTACGTGCCCTCGTAATGGT XbaI 
5021 GAACTCGAATTCAGGCGATG EcoRI 
5022 TTTTCTCGAGACCTGCCATTCGATGAGGAT XhoI 
5023 TTTTCTCGAGGATGGAAGGCAACGACATC XhoI 
5024 TTTTTCTAGAAGTTTCGGCACGAGTTCATC XbaI 
5025 TTTTCTCGAGGCGCGTTTCATCATCGAC XhoI 
5026 TTTTTCTAGAAGATCGCGCACATGAAGG XbaI 
5177 TTTTGAATTCGTCGGGCAACGTATCCAGT EcoRI 
5178 TTTTCTCGAGTATGCTGTCTTCGGTCTCCTG XhoI 
5179 TTTTCTCGAGGTCGGGCAACGTATCCAGT XhoI 
5180 TTTTGAATTCTATGCTGTCTTCGGTCTCCTG EcoRI 
5181 TTTTTCTAGAGATCCGCGTGCTGAACTC XbaI 
5182 TTTTCTCGAGGACGACGTCGACAAGCTC XhoI 
5183 TATAGAATTCGATCGACGACAAGACCGAGT EcoRI 
5184 TATACTCGAGAACCCGTCGTACAGCAAATC XhoI 
5185 TTTTTCTAGAACGTCAGCTGGTTCTTCCAC XbaI 
5186 TTTTCTCGAGGTACCTCGGGCTCAACACGTA XhoI 
5187 TTTTGAATTCATGGCACCTTCGACCTGAC EcoRI 
5188 TTTTCTCGAGGGCTTCGCATCCTCGTAGAC XhoI 
5189 TTTTCTCGAGCGTCAGCTACCTCGACCAACC XhoI 
5190 TTTTTCTAGAGTAGGTGTCGCGCAGCTTCT XbaI 
5191 TTTTGAATTCGTCAGCTACCTCGACCAACC EcoRI 
5192 TTTTCTCGAGGTAGGTGTCGCGCAGCTTCT XhoI 
5193 TTTTCTCGAGGGCAAGTTGATCCTCGACCAG XhoI 
5194 TTTTTCTAGAGGCTCGCTGTCGCATATT XbaI 
5333 TTTTGAATTCTCGTGCTCAACATCAGCTTC EcoRI 
5334 TTTTCTCGAGCCGTAACCCTTTTTCGGATT XhoI 
6066 TTTTGAATTCACCGTACTCGACCCTTCCTT EcoRI 
5887 CTGTCATGCCATCCGTAAGA N/A 
6207 TTTTTTCATATGGAAAGGAGCTATCCGTGCAG NdeI 
6208 TTTTTCTAGACCTACAGGCGCGACAGAT XbaI 
*Restriction endonuclease sites incorporated in the oligonucleotide sequences are underlined. 
N/A indicates absence of restriction site. 
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Table S2. 
 
Annotation of T6SS cluster genes in B. cenocepacia K56-2 
BCAL   Standard Predicted functionb    
Number Annotationa 
 
0352    Putative bacteriophage-like L-alanyl-D-glutamate peptidase; 
    highly conserved in Burkholderia T6SSs (Boyer et al., 2009). 
 
0351  tssM  IcmF-like, inner membrane protein with a cytoplasmic region 
    that has ATPase activity. It makes a complex with TssL and 
    TagL (Felisberto-Rodrigues et al., 2011). 
 
0350  tagF  SciT domain, DUF2094, unknown function. 
 
0349  tagL  OmpA-like peptidoglycan binding domain lipoprotein; PF0691  
    (Aschtgen et al., 2010) 
 
0348  tssA  Cytoplasmic protein (Cascales & Cambillau, 2012). 
 
0347  tssH  ClpV-ATPase for the sheath assembly/disassembly 
    (Bonemann et al., 2009). 
 
0346  tssG  Recruited to the membrane by TssK. 
    (English et al., 2014; Zoued et al., 2013). 
 
0345  tssF  Recruited to the membrane by TssK 
 
0344  tssE  Similarity with the phage gp25 baseplate protein 
 
0343  tssD  hcp-like, hexameric inner tube (Zoued et al., 2014) 
 
0342  tssC  Phage-like sheath subunit (Aubert et al., 2010) 
 
0341  tssB  Phage-like sheath subunit (Aubert et al., 2010) 
 
0340    Outer membrane lipoprotein, NlpI lipoprotein domain. Highly 
    conserved in Burkholderia T6SSs (Boyer et al., 2009) 
 
0339  tssJ  Outer membrane lipoprotein 
    (Felisberto-Rodrigues et al., 2011). 
 
0338  tssK  ImpJ, VasE trimeric complex interacts with TssF and TssG  
    (English et al., 2014; Zoued et al., 2013).  
 
0337  tssL  IcmH-like, dot U, inner membrane (Durand et al., 2012). 
 
0336    DUF4262, conserved in many bacterial and viral proteins. Not 
    part of the B. cenocepacia T6SS (this work) 
 
0335    Conserved hypothetical protein. Not part of the B. cenocepacia 
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    T6SS (this work) 
 
0334    Putative amino-acid transporter periplasmic solute protein. Not 
    part of the B. cenocepacia T6SS (this work) 
 
0333    Putative "winged helix" DNA binding protein. Not part of the B. 
    cenocepacia T6SS (this work) 
 
 
a Based on Shalom et al. (2007) 
b Based on BLASTP 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&PAGE_TYPE=BlastSearch&LINK
_LOC=blasthome) and HHpred (http://toolkit.tuebingen.mpg.de/hhpred) searches.  
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SUPPLEMENTARY METHODS 
 
Details of the construction of mutagenic and complementing plasmids  
 
Mutagenesis of B. cenocepacia K56-2. Unmarked and non-polar deletions were performed as 
described previously (Flannagan et al., 2008). Amplicons were digested with the appropriate 
restriction enzymes and cloned into plasmid pGPI-SceI (see below for details). Mobilization of 
mutagenesis plasmids into Burkholderia strains was performed by triparental mating using E. coli 
DH5α carrying the helper plasmid pRK2013 (Craig et al., 1989; Figurski & Helinski, 1979). 
Gene deletions were confirmed by PCR. Deletion of BCAL1674-76 was performed using plasmid 
pMH447 and resulted in K56-2 gentamicin sensitive strains. 
 
Deletion of genes localized in the T6SS cluster. To delete BCAL0352, PCR amplifications of 
regions flanking BCAL0352 were performed using 3454-3465 and 3458-3457 primer pairs. The 
amplicons were digested with the restriction enzymes XbaI-XhoI and XhoI-EcoRI, respectively, 
and cloned into the mutagenic plasmid pGPI-SceI digested with XbaI and EcoRI giving rise to 
pDelL0352. Several deletion plasmids were created using a similar approach. To create 
pDelL0351, pDelL0350, pDelL0349, pDelL0339, pDelL0338, pDelL0337, and pDelL0336-33 (to 
delete BCAL0351, 0350, 0349, 0339, 0338, 0337 and BCAL0336-0333, respectively), PCR 
products were amplified using primers 3203-3177 and 3201-3202; 5190-5189 and 5188-5187; 
5194-5193 and 5192-5191; 3948-3947 and 5178-5177; 5181-5182 and 5179-5180; 5185-5186 
and 5184-5183; 5026-5025 and 5334-5333, respectively.  
 
Deletion of BCAL0345 paralogs. To create pDelL1293 and pDelS0668 (to delete BCAL1293 
and BCAS0668, respectively), PCR products were amplified using primers 4896-4895 and 4894-
4893; 4902-4901 and 4900-4899, respectively.  
 
Deletion of vgrGs. To create pDelL1165, pDelL1294, pDelL1355, pDelL1359, pDelL1362, 
pDelL2279, pDelM0043, pDelM0148, pDelM2254 and pDelS0667 (to delete BCAL1165, 1294, 
1355, 1359, 1362, 2279, BCAM0043, 0148, 2254 and BCAS0667, respectively), PCR products 
were amplified using primers 3800-3801 and 4185-4186; 3059-3065 and 3066-3068; 3349-3354 
and 5015-5016; 5017-5018 and 5019-5020; 5021-5022 and 5023-5024; 4305-4306 and 4308-
4309; 4125-4126 and 4127-4128, 3759-3760 and 3761-3762; 4134-4135 and 4136-4137, 2863-
3263 and 3267-2867, respectively.  
 
Complementing plasmids. The complementing plasmids pL0345, pL1293, pM1857 and pS0668 
were created as follows. BCAL0345, BCAL1293, BCAM1857 and BCAS0668 were PCR 
amplified using primer pairs 4905-4906, 4897-4898, 6207-6208 and 4903-4904, respectively. 
PCR products were digested with NdeI and XbaI and cloned into similarly digested pDA12. 
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SUPPLEMENTARY FIGURES 
bcj_BCAL0345    1 ----MEELLPYYERELSFLRRYSRDFAERYPKIAARLALSGEHCEDPHVERMIESFALLG 
bcj_BCAL1293    1 ----MDHLLSHYEREVGLLARSLADFARRFPKIAARLGMSGGHVEDLHVDRMVQTFALLA 
bcj_BCAS0668    1 MAIEPEDLLPHFERELGLLRRSTRAFAELYPKIAARLAMSGEHSDDPHVERLLQSFALMC 
 
 
bcj_BCAL0345   57 ARINKKLDDDYPEFTEALLEVLYPHYLRPFPSCSIAQFTP-ASPGQQTEPVVIERGTELK 
bcj_BCAL1293   57 ARVDAKLDDDYPQFTEALLEIAYPHYLRTVPSCAVASFDPSVLFGQLTEPLTIARGTMLD 
bcj_BCAS0668   61 ARHDIRLEDEVPEFTHALINTIHGAFLRPFPSCAMAQFRVDRDSKQ-TEPRIVPRGTQLV 
 
 
bcj_BCAL0345  116 SRPIRGVQCRFRTAYDVTLAPIRISEARYTPVALAPSATVLPSNATGVISITFESLAAQL 
bcj_BCAL1293  117 AN---AAPCRFRTLYDVTLSPLRIYSARYSSATLAPAAARIPAEVTGIISITFTSESASQ 
bcj_BCAS0668  120 AP---NSRLVFRTAADVTLVPLTVSGVRYATSTVAPMQTTLPADTTGILSFTLELTAPSA 
 
 
bcj_BCAL0345  176 DLG-ALKLSTLRAHLHGEQSFVAALTDCLFVNVLGAYVEPERNGRWTALRKLPIAQAGFA 
bcj_BCAL1293  174 AFDDAIPSTPVRVHLSGERPLVAALSDTLLLRASAAYVEVDESGRWTRLSKVPIEAAGFA 
bcj_BCAS0668  177 QFS--IAPDTVRLHLAGEREVVAALADGVLMHATRAFVELDGNGRWRRVD-MPLAAAGFD 
 
 
bcj_BCAL0345  235 EDDALIDYP-AKSHPAYRLLTEYFAFPDKFDFVDFDLAAIARAS--GRCQRATLHLVLQD 
bcj_BCAL1293  234 DGERLLPKQDDTSAQSFRHLIEYFAFPEKFDFVDIDLGRMRRAARAEAARRLTLHVAVQG 
bcj_BCAS0668  234 DADALLPPPRDNTTAPFHLLREYGAFPARFDNLDLDLARLKRLAG--GARRITLHLALAG 
 
 
bcj_BCAL0345  292 VRSDSHVARLLELLMASHFRLFCTPIVNLFRQHGEPIRITHRAVSYPVIAEARR-AFAYE 
bcj_BCAL1293  294 TAHDSGTAQILATLNTSTFRLFCTPVVNLFERAATPIQLTSHDATYPITPTPLATGIPLS 
bcj_BCAS0668  292 VHPDSRCAQRLIAASADNLRLFCTPVVNLFSSNAEPIETKAGQAYYALKPFSLKTAATTE 
 
 
bcj_BCAL0345  351 VYSIDSVKLVR----------QQAHEESVIEFRPFYSLHHG-EAARIGHYWFARRNDWVA 
bcj_BCAL1293  354 VYSVEAVYLGERTKSGEDKAAIASHAAPRTQVWPYRAFSHARPMDSSAIYWLAYRDPETM 
bcj_BCAS0668  352 IWSVDQVRITT--------------AQGAALLPPFESLQHALGAAPGPYWVVLRDEARRA 
 
 
bcj_BCAL0345  400 QKSP----------------------GYETEISIVDIDFEPTSPQTD-TLSLDLTCTNRD 
bcj_BCAL1293  414 PDGA----------------------LAESQLALVDLKGQTAHPRHP-QVDVDVLATNGA 
bcj_BCAS0668  398 PKPPSEPGKPGQEALRGQATGARADGLRGLELALVNARGEPVDPAAQRQLDIVLSCTNGN 
 
 
bcj_BCAL0345  437 LPAMLAFGLEGGDLFQEGGAQTSGISLLRRPTQSVRFERGRAAHWRLVSHLALNHVSLVA 
bcj_BCAL1293  451 MPSRLPIGAPDSDLLYEGSALACPIMLLSRPTLPAALPRG-GALWRVLSALAPHPLDLTR 
bcj_BCAS0668  458 LADMRER-----QLAVRDGDSGDEIELLAQPSASPAPILRRGDLWELLSWLVPQAARLNA 
 
 
bcj_BCAL0345  497 HGLAPLKEMLTLYDLRRTAVSMRQIDGLVGVEQRGAVQWLPGKP-FATFVRGIEIRLTID 
bcj_BCAL1293  510 TGLPALKEFLRFHAPRSSVVAQRCIDAIASLDCKPAIRWMSLDDHFPSFVRGVEILLSVS 
bcj_BCAS0668  513 EGLDELKRLCARFG-MFAPDAGRRFDALVSLSTERMRRWMPGKP-ASAFVQGLEVRLVID 
 
 
bcj_BCAL0345  556 EEHFVGASLASFVRVLDSFFGLYVHLNSFVQLVVVSKRTGEEIIRCKPRTGESILA 
bcj_BCAL1293  570 EAATRDVSLHRFSAVMDRFFGPYAQSNSYVQLVVLSAESDKELLRCAPRPGTQPLV 
bcj_BCAS0668  571 EQRFVQFSLAGLGRVMDRLFSPYVPVTSFVQIVLISAETGVVLRRGEPCAGSQPLI 
 
 
   
Fig. S1  Aubert et al.  
Sequence alignment of BCAL0345 and paralogs (BCAL1293 and BCAS0668). Sequence 
alignment was generated using ClustalW (Larkin et al., 2007). Identical (black) and similar (grey) 
residues were illustrated using BOXSHADE 
(http://www.ch.embnet.org/software/BOX_form.html). 
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